Has Christine Dukes received payments from drug or device companies?

Yes. Drug and device makers reported $4,316 in general payments to Christine Dukes across 281 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Christine Dukes did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Christine Dukes come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Christine Dukes

Internal Medicine · Jasper, GANPI 1174240808

Payments from drug & device makers

$4,316in general payments, 2019–2025

Across 281 payments — averaging $15.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

AbbVie$908
Novo Nordisk$723
Axsome Therapeutics, Inc.$376
Lilly USA, LLC$274
AstraZeneca$213
Takeda Pharmaceuticals U.S.A., Inc.$197
plus $2K from 28 others

What the payments were for

Food & beverage$4,302100%
Other$140%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
AbbVie	98	$908
Novo Nordisk	48	$723
Axsome Therapeutics, Inc.	17	$376
Lilly USA, LLC	17	$274
AstraZeneca	11	$213
Takeda Pharmaceuticals U.S.A., Inc.	9	$197
Sanofi-aventis U.S. LLC	9	$176
Pfizer	8	$170
GSK	7	$158
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)	7	$144
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC	4	$97
Exact Sciences	5	$81
Bayer	4	$80
Boehringer Ingelheim	4	$80
Otsuka America Pharmaceutical, Inc.	4	$75
Idorsia Pharmaceuticals US Inc	4	$70
Corcept Therapeutics	3	$64
Lundbeck LLC	3	$62
Antares Pharma, Inc.	3	$56
Abbott	2	$45
Regeneron Healthcare Solutions, Inc.	1	$30
Vanda Pharmaceuticals Inc.	1	$29
Johnson & Johnson	1	$23
Inspire Medical Systems, Inc.	1	$22
Paratek Pharmaceuticals, Inc.	1	$20
Ascensia Diabetes Care US Inc.	1	$20
Amgen	1	$18
Tolmar, Inc.	1	$17
Azurity Pharmaceuticals, Inc.	1	$17
Novartis	1	$16
Currax Pharmaceuticals LLC	1	$15
Kowa Pharmaceuticals America, Inc.	1	$14
Baxter Healthcare	1	$14
Merck	1	$14

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

VRAYLAR$115

How this compares

$4,316 in reported general payments places this provider in the 85th percentile of 3,311 internal medicine providers in Georgia.

See all internal medicine providers in Georgia →

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Rosuvastatin Calcium	14	$150
Azithromycin	14	$49
Prednisone	32	$39

Paid to pharmacies, not to this prescriber.

Other internal medicine in Jasper

Paul BradleySavannah$76.4M
Kimball JohnsonAtlanta$51.1M
Bram WieskopfWoodstock$21.9M
Dwight BlakeUnion City$13.3M
Charlotte Grayson-MathisFayetteville$9.6M
Christopher RecknorGainesville$9.2M
James HarperJohns Creek$9.2M
Robert Springer IiiAtlanta$5.3M
Thomas MoriaritySavannah$4.6M
Charles KempAlbany$2.7M

See the full list for Georgia →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →